Cargando…

Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease

Acral lentiginous melanoma is a histological subtype of cutaneous melanoma that occurs in the glabrous skin of the palms, soles and the nail unit. Although in some countries, particularly in Latin America, Africa and Asia, it represents the most frequently diagnosed subtype of the disease, it only r...

Descripción completa

Detalles Bibliográficos
Autores principales: Basurto‐Lozada, Patricia, Molina‐Aguilar, Christian, Castaneda‐Garcia, Carolina, Vázquez‐Cruz, Martha Estefania, Garcia‐Salinas, Omar Isaac, Álvarez‐Cano, Alethia, Martínez‐Said, Héctor, Roldán‐Marín, Rodrigo, Adams, David J., Possik, Patricia A., Robles‐Espinoza, Carla Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818404/
https://www.ncbi.nlm.nih.gov/pubmed/32330367
http://dx.doi.org/10.1111/pcmr.12885
Descripción
Sumario:Acral lentiginous melanoma is a histological subtype of cutaneous melanoma that occurs in the glabrous skin of the palms, soles and the nail unit. Although in some countries, particularly in Latin America, Africa and Asia, it represents the most frequently diagnosed subtype of the disease, it only represents a small proportion of melanoma cases in European‐descent populations, which is partially why it has not been studied to the same extent as other forms of melanoma. As a result, its unique genomic drivers remain comparatively poorly explored, as well as its causes, with current evidence supporting a UV‐independent path to tumorigenesis. In this review, we discuss current knowledge of the aetiology and diagnostic criteria of acral lentiginous melanoma, as well as its epidemiological and histopathological characteristics. We also describe what is known about the genomic landscape of this disease and review the available biological models to explore potential therapeutic targets.